Cardiovascular technology developer Cordis announced today that it appointed Dr. George Adams as its new chief medical officer.
Miami Lakes, Florida-based Cordis said in a news release that the hiring of Adams furthers its mission to differentiate itself as a technological leader and value-based global medical device company.
“We are delighted to have Dr. Adams join our team as we continue to build the new Cordis,” Corids CEO Shar Matin said in the release. “His depth of expertise in the treatment of both complex coronary and peripheral vascular disease will play a vital role in furthering our mission to improve patient care at pace with cost-effective, differentiated solutions that build on our legacy of innovation.”
Adams joins Corids with a combination of clinical practice, medical research and product development experience, the company said. He has expertise in treating peripheral vascular disease in patients with critical limb ischemia (CLI) and coronary artery disease and is involved in the development of regional and national systems of care for treating CLI, ST-elevation myocardial infarction and the management of complex coronary and peripheral vascular disease.
He has also served as the primary investigator for multiple clinical trials and is certified by The American Board of Internal Medicine in internal medicine and cardiovascular disease.
“It is with great honor and excitement that I join the Cordis team as chief medical officer,” Adams said. “I look forward to playing a role in reinvigorating an incredible 62-year legacy. I am grateful to be a part of the future that Cordis is building with integrity and a vision for innovation.”